THE AI-BOOSTER
FOR SKIN PATHOLOGY
Innovative
transformation in skin pathology
Through the use of state-of-the-art artificial intelligence, aisencia® streamlines the workflow in skin pathology to meet the growing demand for fast, precise, and accessible diagnoses

At aisencia®, we explore and develop in ultra-close cooperation with world leading skin pathologists to meet their current and future needs
Partner / Supporters
Already analyzed samples
AI-assisted skin diagnoses
Publications
Our partners
Recent posts
Explore the recent happenings, developments, and trends in our continuous endeavor to revolutionize pathology
Successful Implementation of our LIS at Dermatologikum Hamburg
Our team has successfully implemented Vistaneos, our innovative Laboratory Information System (LIS), at Dermatologikum Hamburg, one of Germany’s leading dermatopathology institutes.
The digital pathology workplace of the future
As part of the AI-Path project, aisencia GmbH and the Digital Media Lab at the University of Bremen are joining forces to redefine how pathologists work in the digital age.
aisencia® secures €150 000 BRE-Up funding for “DERM-BOOST”
aisencia GmbH has been awarded €150,000 in EU funding through the BRE-Up program to further develop its digital, AI-powered software solutions Vistaneos and Cutaneos 80.
aisencia® expands to Australia and welcomes new investor
We are extremely proud to welcome Pathscan Pty Ltd. from Australia as a strategic partner and investor—alongside industry leaders Dr. Ian Katz and Paul Richard.
aisencia® partners with PathPresenter!
We are thrilled to announce an strategic partnership with PathPresenter. This collaboration marks a significant milestone by expanding our offerings to the US market.
Introducing Vistaneos: A New Era of Seamless Dermatopathology
This innovative product integrates a laboratory information system, an image management system, and DermPath AI, enabling a seamlessly optimized laboratory workflow.
Supported by

You want to know more information about our products?



























